Inhibitor-mediated stabilization of the conformational structure of a histone deacetylase-like amidohydrolase

FEBS Journal

Volumn 274, Issue 14, 2007, Pages 3578-3588

  Kern, Stefanie ^a   Riester, Daniel ^b   Hildmann, Christian ^b   Schwienhorst, Andreas ^b   Meyer Almes, Franz Josef ^a  

^a DARMSTADT UNIVERSITY OF APPLIED SCIENCES   (Germany)

^b Inst fuer Mikrobiologie und Genetik   (Germany)

Author keywords

FB188; HDAH; Histone deacetylase; Protein denaturation; Protein stablization

Indexed keywords

AMIDASE; AMIDOHYDROLASE INHIBITOR; GUANIDINE; HISTONE DEACETYLASE; HYDROXAMIC ACID DERIVATIVE; POTASSIUM; VORINOSTAT; ZINC;

ARTICLE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME CONFORMATION; ENZYME DENATURATION; ENZYME KINETICS; ENZYME STABILITY; ENZYME STRUCTURE; PRIORITY JOURNAL; PROTEIN FOLDING;

BORDETELLA; ENZYME INHIBITORS; ENZYME STABILITY; HISTONE DEACETYLASES; KINETICS; POTASSIUM; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN FOLDING; ZINC;

EUKARYOTA;

EID: 34447299672     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2007.05887.x     Document Type: Article

References (52)

1. Hildmann C, Riester D Schwienhorst A (2007) Histone deacetylases an important class of cellular regulators with a variety of functions. Appl Microbiol Biotechnol 75, 487 497.
2. Struhl K (1998) Histone acetylation and transcriptional regulatory mechanisms. Genes Dev 12, 599 606.
3. Zhang Y Reinberg D (2001) Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev 15, 2343 2360.
4. Cosgrove MS Wolberger C (2005) How does the histone code work? Biochem Cell Biol 83, 468 476.
5. Ferreira R, Naguibneva I, Mathieu M, it-Si-Ali S, Robin P, Pritchard LL Harel-Bellan A (2001) Cell cycle-dependent recruitment of HDAC-1 correlates with deacetylation of histone H4 on an Rb-E2F target promoter. EMBO Report 2, 794 799.
6. Richon V Berrie C. (2002) Histone Deacetylase Inhibitors - Redefining Pharmaceutical Approaches to the Treatment of Cancer. LeadDiscovery, Bodiam, UK. Ref. Type: Generic.
7. Riester D, Hildmann C Schwienhorst A (2007) Histone deacetylase inhibitors turning epigenic mechanisms of gene regulation into tools of therapeutic intervention in malignant and other diseases. Appl Microbiol Biotechnol 75, 499 514.
8. Gregoretti IV, Lee YM Goodson HV (2004) Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J Mol Biol 338, 17 31.
9. Grozinger CM Schreiber SL (2002) Deacetylase enzymes: biological functions and the use of small-molecule inhibitors. Chem Biol 9, 3 16.
10. Finnin MS, Donigian JR, Cohen A, Richon VM, Rifkind RA, Marks PA, Breslow R Pavletich NP (1999) Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 401, 188 193.
11. Vannini A, Volpari C, Filocamo G, Casavola EC, Brunetti M, Renzoni D, Chakravarty P, De Paolini CFR, Gallinari P, Di Steinkuhler C et al. (2004) Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases. Structure 12, 1325 1334.
12. Somoza JR, Skene RJ, Katz BA, Mol C, Ho JD, Jennings AJ, Luong C, Arvai A, Buggy JJ, Chi E et al. (2004) Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases. Structure 12, 1325 1334.
13. Nielsen TK, Hildmann C, Dickmanns A, Schwienhorst A Ficner R (2005) Crystal structure of a bacterial class 2 histone deacetylase homologue. J Mol Biol 354, 107 120.
14. Ahmad F, Yadav S Taneja S (1992) Determining stability of proteins from guanidinium chloride transition curves. Biochem J 287, 481 485.
15. Pace CN (1990) Conformational stability of globular proteins. Trends Biochem Sci 15, 14 17.
16. Privalov PL Gill SJ (1988) Stability of protein structure and hydrophobic interaction. Adv Protein Chem 39, 191 234.
17. Baldwin RL (1986) Temperature dependence of the hydrophobic interaction in protein folding. Proc Natl Acad Sci USA 83, 8069 8072.
18. Das G, Hickey DR, McLendon D, McLendon G Sherman F (1989) Dramatic thermostabilization of yeast iso-1-cytochrome c by an asparagine - isoleucine replacement at position 57. Proc Natl Acad Sci USA 86, 496 499.
19. Wilson CJ, Apiyo D Wittung-Stafshede P (2004) Role of cofactors in metalloprotein folding. Q Rev Biophys 37, 285 314.
20. Bushmarina NA, Blanchet CE, Vernier G Forge V (2006) Cofactor effects on the protein folding reaction: acceleration of alpha-lactalbumin refolding by metal ions. Protein Sci 15, 659 671.
21. Pace CN Grimsley GR (1988) Ribonuclease T1 is stabilized by cation and anion binding. Biochemistry 27, 3242 3246.
22. Cashikar AG Rao NM (1996) Unfolding pathway in red kidney bean acid phosphatase is dependent on ligand binding. J Biol Chem 271, 4741 4746.
23. Lin LN, Mason AB, Woodworth RC Brandts JF (1994) Calorimetric studies of serum transferrin and ovotransferrin. Estimates of domain interactions, and study of the kinetic complexities of ferric ion binding. Biochemistry 33, 1881 1888.
24. Plotnikov V, Rochalski A, Brandts M, Brandts JF, Williston S, Frasca V Lin LN (2002) An autosampling differential scanning calorimeter instrument for studying molecular interactions. Assay Drug Dev Technol 1, 83 90.
25. Bernier V, Lagace M, Lonergan M, Arthus MF, Bichet DG Bouvier M (2004) Functional rescue of the constitutively internalized V2 vasopressin receptor mutant R137H by the pharmacological chaperone action of SR49059. Mol Endocrinol 18, 2074 2084.
26. Petaja-Repo UE, Hogue M, Bhalla S, Laperriere A, Morello JP Bouvier M (2002) Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation. EMBO J 21, 1628 1637.
27. Chaudhuri TK Paul S (2006) Protein-misfolding diseases and chaperone-based therapeutic approaches. FEBS J 273, 1331 1349.
28. Hildmann C, Ninkovic M, Dietrich R, Wegener D, Riester D, Zimmermann T, Birch OM, Bernegger C, Loidl P Schwienhorst A (2004) A new amidohydrolase from Bordetella or Alcaligenes strain FB188 with similarities to histone deacetylases. J Bacteriol 186, 2328 2339.
29. Riester D, Wegener D, Hildmann C Schwienhorst A (2004) Members of the histone deacetylase superfamily differ in substrate specificity towards small synthetic substrates. Biochem Biophys Res Commun 324, 1116 1123.
30. Hildmann C, Wegener D, Riester D, Hempel R, Schober A, Merana J, Giurato L, Guccione S, Nielsen TK, Ficner R et al. (2006) Substrate and inhibitor specificity of class 1 and class 2 histone deacetylases. J Biotechnol 124, 258 270.
31. Ray S, Bhattacharyya M Chakrabarti A (2005) Conformational study of spectrin in presence of submolar concentrations of denaturants. J Fluoresc 15, 61 70.
32. Chakrabarti A Basak S (1996) Structural alterations of horseradish peroxidase in the presence of low concentrations of guanidinium chloride. Eur J Biochem 241, 462 467.
33. Riester D, Hildmann C, Schwienhorst A Meyer-Almes FJ (2007) Histone deacetylase inhibitor assay based on fluorescence resonance energy transfer. Anal Biochem 362, 136 141.
34. Maxwell KL, Wildes D, Zarrine-Afsar A, De Los Rios MA, Brown AG, Friel CT, Hedberg L, Horng JC, Bona D, Miller EJ et al. (2005) Protein folding: defining a 'standard' set of experimental conditions and a preliminary kinetic data set of two-state proteins. Protein Sci 14, 602 616.
35. Silow M Oliveberg M (1997) Transient aggregates in protein folding are easily mistaken for folding intermediates. Proc Natl Acad Sci USA 94, 6084 6086.
36. Otzen DE, Kristensen O Oliveberg M (2000) Designed protein tetramer zipped together with a hydrophobic Alzheimer homology: a structural clue to amyloid assembly. Proc Natl Acad Sci USA 97, 9907 9912.
37. Kiefhaber T, Kohler HH Schmid FX (1992) Kinetic coupling between protein folding and prolyl isomerization. I. Theoretical models. J Mol Biol 224, 217 229.
38. Kiefhaber T, Grunert HP, Hahn U Schmid FX (1990) Replacement of a cis proline simplifies the mechanism of ribonuclease T1 folding. Biochemistry 29, 6475 6480.
39. Jackson SE Fersht AR (1991) Folding of chymotrypsin inhibitor 2. 2. Influence of proline isomerization on the folding kinetics and thermodynamic characterization of the transition state of folding. Biochemistry 30, 10436 10443.
40. Fersht AR (1999) Structure and Mechanism in Protein Science. A Guide to Enzyme Catalysis and Protein Folding. Freeman, New York, NY.
41. Nall B (1994) Mechanism of Protein Folding. IRL Press, Oxford.
42. Matouschek A, Kellis JT Jr., Serrano L Fersht AR (1989) Mapping the transition state and pathway of protein folding by protein engineering. Nature 340, 122 126.
43. Denton ME, Rothwarf DM Scheraga HA (1994) Kinetics of folding of guanidine-denatured hen egg white lysozyme and carboxymethyl (Cys6,Cys127)-lysozyme: a stopped-flow absorbance and fluorescence study. Biochemistry 33, 11225 11236.
44. Baldwin RL (1996) On-pathway versus off-pathway folding intermediates. Fold Des 1, R1 R8.
45. Fenrick R Hiebert SW (1998) Role of histone deacetylases in acute leukemia. J Cell Biochem Supplement 30-31, 194 202.
46. Bouchain G Delorme D (2003) Novel hydroxamate and anilide derivatives as potent histone deacetylase inhibitors: synthesis and antiproliferative evaluation. Curr Med Chem 10, 2359 2372.
47. Munster PN, Troso-Sandoval T, Rosen N, Rifkind R, Marks PA Richon VM (2001) The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells. Cancer Res 61, 8492 8497.
48. Moreth K, Riester D, Hildmann C, Hempel R, Wegener D, Schober A Schwienhorst A (2006) An active site tyrosine is essential for amidohydrolase but not for esterase activity of a class 2 histone deacetylase-like bacterial enzyme. Biochem J 401, 659 665.
49. Wegener D, Wirsching F, Riester D Schwienhorst A (2003) A fluorogenic histone deacetylase assay well suited for high-throughput activity screening. Chem Biol 10, 61 68.
50. Wegener D, Hildmann C, Riester D Schwienhorst A (2003) Improved fluorogenic histone deacetylase assay for high-throughput-screening applications. Anal Biochem 321, 202 208.
51. Santoro MM Bolen DW (1988) Unfolding free energy changes determined by the linear extrapolation method. 1. Unfolding of phenylmethanesulfonyl alpha-chymotrypsin using different denaturants. Biochemistry 27, 8063 8068.
52. Mogensen JE, Ipsen H, Holm J Otzen DE (2004) Elimination of a misfolded folding intermediate by a single point mutation. Biochemistry 43, 3357 3367.